1 UCL Centre for Nephrology, Royal Free Hospital, University College London, London, UK.
Nutr Clin Pract. 2017 Oct;32(5):682-686. doi: 10.1177/0884533617697936. Epub 2017 Mar 22.
Muscle weakness is a risk factor for mortality in hemodialysis (HD) patients. Muscle strength measurements are routinely used as a screening tool but depend on patient cooperation and motivation. We wished to determine whether measuring maximal voluntary muscle strength was affected by patient self-reported distress.
We measured pinch strength (PS) and handgrip strength (HGS) in 382 adult HD patients with a corresponding self-reported distress thermometer (DT) scores. Postdialysis body composition measurements were made using multifrequency bioelectrical assessments and patients assessed for frailty.
Mean age was 66.4 ± 14.9 years, with 238 males (62%), 48% diabetic, and dialysis vintage 36 (15-75) months. The mean DT score was 4.4 ± 3.3, with a frailty score of 4.6 ± 1.5. On multivariable analysis, DT scores were associated with frailty (β = 0.35, P = .003), prescription of aspirin for cardiac disease (β = 1.0, P = .004), lean body mass (β = 0.04, P = .004), and negatively with age (β = -0.05, P < .001), hematocrit (β = -8.2, P = .004), and maximum PS (β = -1.4, P = .003).
Paradoxically higher self-reported DT scores were associated with younger age and lean body mass. As such, younger healthier, rather than more comorbid, patients may have greater expectations for their health and therefore report more distress. We found no association between DT scores and HGS, and as such, although HGS is a voluntary test, it appears to be a robust test independent of patient stresses. However, PS was lower in patients with higher DT scores, and as such, greater care may be required in interpreting these measurements.
肌肉无力是血液透析(HD)患者死亡的一个危险因素。肌肉力量测量通常被用作筛查工具,但取决于患者的合作和积极性。我们希望确定测量最大自主肌肉力量是否受患者自我报告的痛苦程度的影响。
我们测量了 382 名成年 HD 患者的捏力(PS)和手握力(HGS),并与相应的自我报告痛苦温度计(DT)评分进行了比较。透析后使用多频生物电阻抗评估进行身体成分测量,并评估患者的虚弱程度。
平均年龄为 66.4 ± 14.9 岁,男性 238 人(62%),糖尿病患者占 48%,透析时间为 36(15-75)个月。平均 DT 评分 4.4 ± 3.3,虚弱评分 4.6 ± 1.5。多变量分析显示,DT 评分与虚弱(β=0.35,P=0.003)、因心脏病开具阿司匹林(β=1.0,P=0.004)、瘦体重(β=0.04,P=0.004)呈正相关,与年龄(β=-0.05,P<0.001)、红细胞压积(β=-8.2,P=0.004)和最大 PS(β=-1.4,P=0.003)呈负相关。
矛盾的是,更高的自我报告 DT 评分与更年轻和瘦体重相关。因此,更年轻、更健康而非更多合并症的患者可能对自己的健康有更高的期望,因此报告的痛苦更多。我们没有发现 DT 评分与 HGS 之间的关联,因此,尽管 HGS 是一项自愿测试,但它似乎是一项独立于患者压力的可靠测试。然而,在 DT 评分较高的患者中,PS 较低,因此在解释这些测量值时需要更加小心。